Dr. Reddy's gets 2 observations from USFDA for Hyderabad Plant

28 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy's Laboratories’ Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad. The company has been issued a Form 483 with 2 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1158.40 -8.50 (-0.73%)
21-Jan-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.80
Dr. Reddys Lab 1158.40
Cipla 1373.35
Zydus Lifesciences 877.10
Lupin 2163.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×